William T Abraham

William T Abraham

Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine

FAHA FRCP MD FACC

Ohio State University, Columbus, OH, US

  • LinkedIn
  • Radcliffe

Research areas

Heart Failure

Biography

Prof Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years.

His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve stimulation, cardiac contractility modulation, baroreflex activation therapy, and mitral valve repair.

Prof Abraham has authored more than 1,000 original works and has been named a Clarivate Analytics Highly Cited Researcher and one of The World’s Most Influential Scientific Minds.

He received the 2017 Distinguished Scientist Award from the American College of Cardiology.

With his permission, Prof Abraham is contactable here.

Read more

Media

CardioNerds @AHA23: Speech Analysis to Detect Worsening HF in ADHF Patients

William T Abraham, Hanad Bashir

Watch time: 8m 35s

Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al

Watch time: 15h 45m 20s (18 videos)

William T Abraham, Marianna Adamo, Stefan Anker, et al

William T Abraham, Marianna Adamo, Stefan Anker, et al

William T Abraham

Watch time: 9m 6s

John JV McMurray, Yuhui Zhang, Giuseppe Rosano, et al

Watch time: 17h 35m (23 videos)
HFSA 22: HearO™ Community Study: Remote Speech Analysis of Hospitalized Pts With Acute Decompensated HF New Technology

William T Abraham

Watch time: 8m 14s
EMPERIAL in Review – Effects of Empagliflozin on Exercise Ability

William T Abraham

Watch time: 11m 27s

Thomas M Helms, Karl-Heinz Kuck, William T Abraham, et al

Watch time: 1h 15m 6s
HFA 2018: FIX-5C And The EU Registry - Cardiac Contractility Modulation In HFrEF - Prof William Abraham

William T Abraham

Watch time: 2m 52s
HFA 2018: GENETIC-AF -Pharmacogenetic Guided Beta-Blocker Therapy - Prof William Abraham

William T Abraham

Watch time: 4m 4s

Articles by William T Abraham, Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine

Identification and Treatment of Central Sleep Apnoea: Beyond SERVE-HF

William T Abraham, Adam Pleister, Robin Germany, et al

Citation: Cardiac Failure Review 2018;4(1):50–3.

DOI:

https://doi.org/10.15420/cfr.2018:9:1
Managing Hyponatraemia in Heart Failure

William T Abraham,

Citation: European Cardiology 2008;4(2):39–41

DOI:

https://doi.org/10.15420/ecr.2008.4.2.39
Transvenous Phrenic Nerve Stimulation - A Novel Therapy for Central Sleep Apnea in Heart Failure

Sitaramesh Emani, William T Abraham,

Citation: US Cardiology 2012;9(1):53-6

DOI:

https://doi.org/10.15420/usc.2012.9.1.53
Transvenous Phrenic Nerve Stimulation - A Novel Therapy for Central Sleep Apnoea in Heart Failure

Sitaramesh Emani, William T Abraham,

Citation: European Cardiology 2012;8(1):44-7

DOI:

https://doi.org/10.15420/ecr.2012.8.1.44
Managing Hyponatremia in Heart Failure

William T Abraham,

Citation: US Cardiology 2008;5(1):57–60

DOI:

https://doi.org/10.15420/usc.2008.5.1.57
Central Sleep Apnea in Heart Failure

Rami Khayat, Andrew Pederzoli, William T Abraham, et al

Citation: US Cardiology 2009;6(2):72–8

DOI:

https://doi.org/10.15420/usc.2009.6.2.72